Observational studyPharmacology research & perspectives2021

Increase in the risk of clopidogrel resistance and consequent TIMI flow impairment by DNA hypomethylation of CYP2C19 gene in STEMI patients undergoing primary percutaneous coronary intervention (PPCI).

Renan Sukmawan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.